# AbbVie Inc. (ABBV) — Q4-2015 Earnings Results

**Report date:** 2016-01-29 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2015

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 1.7%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.13 | N/A | +0.44% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and market position. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> Management highlighted the continued strength in their core products.

> They emphasized ongoing investments in research and development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.7% on the day, likely due to the lack of revenue data and absence of forward guidance, which may have left investors feeling uncertain about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2015_